Apollo Technology Capital Corporation, which together with its affiliates and associates collectively is one of the largest shareholders of MediPharm Labs (MEDIF), owning approximately 3% of the Company’s common stock, issued a presentation to set forth their ambitious plan to grow your investment and help turn MediPharm around. The company said the presentation, “Outlines Commitment to Immediately and Aggressively Execute on Action Plan to 10X+ Share Price and Create Value for All Shareholders; Details Specific and Measurable Initiatives to Save MediPharm Labs from Insolvency at the Hands of Greedy, Reckless, and Maligned Leaders; Sets Forth Plan to Stop Exorbitant Executive Compensation Pay-for-Failure and End 3 Years of Value Destructive Actions.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDIF:
- MediPharm Labs Sells Hope Facility and Expands EU GMP Cultivation
- Medipharm Labs closes sale of Hope facility, plans to expand Napanee capacity
- Check-Cap ‘publicly condemned’ MediPharm Labs, Chairman Chris Taves
- ISS Backs MediPharm Labs’ Board Nominees, Rejects Apollo’s Claims
- Medipharm Labs says ISS recommends shareholders vote for director nominees